Engage Bio

Engage Bio is dedicated to pioneering the next generation of cancer treatments through the development of innovative mRNA immunotherapies. Our mission is to harness the power of mRNA technology to instruct cancer cells to produce and slowly release therapeutic agents directly within solid tumors. This targeted approach allows for the effective elimination of cancerous cells while minimizing harm to healthy tissues located elsewhere in the body. Our founding team brings extensive expertise in immunotherapy drug development, with a proven track record of advancing four drugs into clinical trials, as well as in the creation of robust mRNA therapeutics platforms. We are committed to revolutionizing cancer treatment and improving patient outcomes.